Specific antisense oligonucleotide treatment against MALAT1 inhibits tumor growth in mouse breast cancer and human NSCLC metastasis models (Arun et al., 2016; Gutschner et al., 2013). Here, MALAT1 is linked to non-small cell lung carcinoma.